Parexel acquires ClinIntel

Published: 6-Oct-2014
Regulatory Research & Development

Extending its clinical randomisation and trial supply management services


Parexel, a global clinical research organisation headquartered near Boston, MA in the US, has acquired all of the outstanding equity securities of privately-owned UK-based ClinIntel, a provider of clinical Randomisation and Trial Supply Management (RTSM) services.

No financial details have been revealed.

ClinIntel's offerings will be combined into the ClinPhone RTSM suite and are designed to make patient randomisation and clinical supply chain solutions more efficient. Capabilities include advanced RTSM technologies for planning, forecasting and supply cahin eLogistics.

The entire ClinPhone RTSM suite will be available through the Perceptive MyTrials platform and as a standalone solution, and both will be available through the Perceptive Partner Program.

ClinIntel, headquartered in Crawley, was founded in 2009 and works with biopharmaceutical companies and contract research organisations. The business will be integrated into the Parexel Informatics segment.

Josef von Rickenbach, Chairman and CEO of Parexel, said: 'By combining the trial supply management technologies from ClinIntel with our existing ClinPhone solutions, we believe we have an opportunity to further advance our position as a clinical technology leader and grow market share by bringing enhanced speed, efficiency, and simplicity to our RTSM offering.'

  • Companies:
  • Parexel International
See more

You may also like

Regulatory

Innovation in clinical trials

Read more
Clinical trials have undergone significant technological and regulatory developments during the past decade; and now, following the rise of the IoT (Internet of Things), the pharma industry is poised for even more change

Trending Articles

  1. Thermo Fisher Scientific reveals MagMax Sequential DNA/RNA Kit to advance blood cancer research The kit combines DNA and RNA isolation chemistries into a single kit, simplifying sample extraction for a broad range of downstream molecular applications
  2. Accelerating and enhancing toxicology assessments Infographic guides users through ToxHQ’s speedy assessment features
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  4. Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
  5. Thermo Fisher Scientific officially opens US oral solid dose testing and R&D facility The company's further expansion in the Bend, Oregon area will assist its pharmaceutical clients in the early development of oral solid dosage (OSD) forms

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Regulatory

Innovation in clinical trials

Clinical trials have undergone significant technological and regulatory developments during the past decade; and now, following the rise of the IoT (Internet of Things), the pharma industry is poised for even more change
Regulatory

PAREXEL announces definitive agreement to acquire The Medical Affairs Company

Acquisition will strengthen and add scale to current commercialisation and medical affairs services
Regulatory

PAREXEL launches IDMP-focused software and service solution

Solution developed to help biopharmaceutical companies meet emerging regulatory requirements ahead of deadline
Regulatory

Parexel and EMC to provide cloud-based document and regulatory information management services

Parexel enhances Regulatory Cloud and leverages EMC Documentum for Life Sciences software to offer regulatory solution
Regulatory

Opinion: Between a rock and a hard place

The tragic death of a healthy volunteer in a Phase I clinical trial emphasises how little we really know about the human organism
Regulatory

Parexel launches IMPACT Express clinical trial management system

Simplifies clinical trial management and monitoring for small-to-mid-sized biopharmaceutical companies
Research & Development

Parexel expands clinical trial supply and logistics services

Opens a European coordination hub and distribution centre in Berlin, Germany
Subscribe now